Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Sanara Capital is a health-tech venture capital fund founded in 2023 and based in Israel. The firm focuses on Series A and B financing rounds for Israeli-related startups, both domestically and internationally. It is a follow-on fund of Sanara Ventures, which was established in 2015 and is backed by industry leaders Philips and Teva.
Sanara Capital invests in health-tech sectors, specifically targeting Digital Health, Bio-Convergence, and Medical Devices. The fund supports companies in Series A and B financing rounds, aiming to build a diversified portfolio of nearly 20 companies across both funds.
Notable portfolio companies include NanoDrops, which develops technology for visual optical correction; CVaid Medical, focusing on advanced diagnostic tools for early stroke detection; Lydus Medical, innovating in automated microvascular anastomosis; and QLog, providing a digital platform to improve operational readiness in healthcare facilities.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.